Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$IMVT

Immunovant, Inc. Common Stock

XNASHealth CareBiological Products, (No Diagnostic Substances)

$44.41+0.14%+$0.0600Prev $44.35LIVE Full chart Live alerts
No recent price bars, the chart lights up when IMVT starts printing.

Why is IMVT up today? It is at $44.41 (+0.14%), and our scanner flagged it 140 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IMVT spikes, and full due diligence on IMVT — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $IMVT alerts the moment volume spikes

Our scanner flagged $IMVT 140 times in the last 30 days. Create a free account to track $IMVT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$44.41
Change today
+0.14%
Previous close
$44.35
52-week range
$14.47 – $45.42
Valuation & dividend
Market cap
$9.16B
Ownership & volume
Shares outstanding
206.6M
Live vendor count
Institutional own.
57.35%
Total held
57.4%
Tradeable float
88.1M
43% of shares · after 57% institutions
Short interest
16.4M
▼ -8% vs prior · as of 2026-07-31
Short % of float
18.6%
Days to cover
18.5d
Avg daily volume
1.6M
Classification
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
XNAS
Relative volumevs this time of day
5mthin
0.4x
15mthin
0.4x
1hthin
0.4x
1D
0.0x

Get free IMVT + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $IMVT moving today?

Here is the latest on IMVT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMVT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Why is $IMVT moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy10 analysts
Avg target $51.90(+17% upside)
Range $30 - $66
9 buy1 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

Insiders selling0 buys, 16 sells last 3 months (12/38 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Pande Atul
Director
Sold (automatic/other)-2Ksold 1.3%117K$60K
at $39.80
Jul 24, 26
Pande Atul
Director
Other2Kadded 1.3%118K$13K
at $8.43
Jul 24, 26
Stout Jay S
Officer
Sold (automatic/other)-3Ksold 1.4%205K$111K
at $38.69
Jul 23, 26
Girao Tiago
Officer
Sold (automatic/other)-7Ksold 2.7%241K$263K
at $38.69
Jul 23, 26
Stout Jay S
Officer
Sold (automatic/other)-3Ksold 1.6%208K$138K
at $39.53
Jul 8, 26
Van Tuyl Christopher
Officer
Sold (automatic/other)-1Ksold 0.7%179K$48K
at $39.53
Jul 8, 26
Gloria Melanie
Officer
Sold (automatic/other)-2Ksold 0.9%222K$80K
at $39.53
Jul 8, 26
Venker Eric
Officer
Sold (automatic/other)-3Ksold 1.2%254K$119K
at $38.48
Jul 2, 26
Venker Eric
Officer
Sold (automatic/other)-87K
0.04% of company
sold 25%257K$3.3M
at $38.14
Jul 1, 26
Venker Eric
Officer
Other92K
0.04% of company
added 37%344K$1.3M
at $14.46
Jul 1, 26
Pande Atul
Director
Sold (automatic/other)-2Ksold 1.3%117K$57K
at $38.01
Jun 26, 26
Pande Atul
Director
Other2Kadded 1.3%118K$13K
at $8.43
Jun 26, 26

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

Dilution watch

Recent offering

Recent priced share offering — a one-time sale that has already completed (not ongoing). If $IMVT runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$IMVT Sentiment

Bullish
Bearish67Bullish
📰 News: 4 bull · 1 bearToday: +0.1%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$IMVT Activity

News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

Alert· 23h ago 2.5× RVOL
IMVT hit 2.537x RVOL at 9:27 AM ET
at $44.51
Alert· 1d ago +0.9% vs EMA
IMVT 200EMA (1m) Trending · 230 bars · L5 · +0.90% above EMA · slope +0.14%
at $44.92
Alert· 1d ago +1.06%
$IMVT moved +1.06% in 1 min (Level 1) at 1:21 PM ET
at $44.69
Alert· 1d ago 9.5× RVOL
IMVT hit 9.484x RVOL at 1:05 PM ET
at $44.43
Alert· 1d ago +0.2% vs EMA
$IMVT near 200 EMA: +0.23% from 200 EMA at 1:04 PM ET
at $44.29
Alert· 1d ago 2.3× RVOL
IMVT hit 2.305x RVOL at 1:04 PM ET
at $44.29
Alert· 1d ago +0.6% vs EMA
$IMVT near 200 EMA: +0.59% from 200 EMA at 12:01 PM ET
at $44.41
Alert· 1d ago 5.8× RVOL
IMVT hit 5.839x RVOL at 12:01 PM ET
at $44.41
Alert· 1d ago 2.3× RVOL
IMVT hit 2.276x RVOL at 10:20 AM ET
at $44.94
Alert· 1d ago 2.6× RVOL
IMVT hit 2.639x RVOL at 9:43 AM ET
at $45.00
Alert· 2d ago 6.3× RVOL
IMVT hit 6.322x RVOL at 3:37 PM ET
at $43.78
Alert· 3d ago +1.1% vs EMA
IMVT 200EMA (1m) Trending · 191 bars · L4 · +1.14% above EMA · slope +0.29%
at $43.74
Alert· 3d ago +1.1% vs EMA
IMVT 200EMA (1m) Trending · 191 bars · L4 · +1.14% above EMA · slope +0.29%
at $43.74
Alert· 3d ago +1.5% vs EMA
$IMVT near 200 EMA: +1.45% from 200 EMA at 3:16 PM ET
at $43.87
Alert· 3d ago 2.9× RVOL
IMVT hit 2.935x RVOL at 3:16 PM ET
at $43.87
Alert· 3d ago +3.2% vs EMA
IMVT 200EMA (5m) Trending · 53 bars · L3 · +3.24% above EMA · slope +0.61%
at $43.76
Alert· 3d ago +1.3% vs EMA
IMVT 50EMA (5m) Trending · 53 bars · L3 · +1.29% above EMA · slope +1.03%
at $43.76
Alert· 3d ago +1.8% vs EMA
$IMVT near 200 EMA: +1.78% from 200 EMA at 2:18 PM ET
at $43.77
Alert· 3d ago 2.1× RVOL
IMVT hit 2.093x RVOL at 2:18 PM ET
at $43.77
Alert· 3d ago +1.5% vs EMA
$IMVT near 200 EMA: +1.53% from 200 EMA at 1:02 PM ET
at $43.24
Alert· 3d ago 2.4× RVOL
IMVT hit 2.372x RVOL at 1:02 PM ET
at $43.24
Alert· 3d ago +0.7% vs EMA
IMVT 50EMA (1m) Trending · 52 bars · L3 · +0.71% above EMA · slope +1.03%
at $43.25
Alert· 3d ago +0.6% vs EMA
IMVT 50EMA (1m) Trending · 51 bars · L3 · +0.58% above EMA · slope +1.07%
at $43.18
Alert· 4d ago 4.3× RVOL
IMVT hit 4.298x RVOL at 8:20 AM ET
at $41.75
Alert· 6d ago +0.1% vs EMA
IMVT 50EMA (1m) Trending · 117 bars · L4 · +0.06% above EMA · slope +0.18%
at $41.65
News· GlobeNewswire Inc.· 59d ago Neutral
Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight
News· GlobeNewswire Inc.· 79d ago Bullish
Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight
News· GlobeNewswire Inc.· 127d ago Bullish
Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight
News· GlobeNewswire Inc.· 141d ago Bearish
Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
News· GlobeNewswire Inc.· 196d ago Bullish
Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025
News· The Motley Fool· 246d ago Neutral
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million?
News· GlobeNewswire Inc.· 337d ago Neutral
CENTURY ALUMINUM INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Century Aluminum Co. - CENX
News· The Motley Fool· 351d ago Bullish
Why Immunovant Stock Blasted Higher Today

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

IMVT stock FAQ

Why is $IMVT moving today?

Here is the latest on IMVT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMVT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the IMVT stock price today?

IMVT last traded at $44.41, up 0.14% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live IMVT alerts?

The IMVT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IMVT 140 times in the last 30 days.

What exchange is IMVT on?

IMVT (Immunovant, Inc. Common Stock) trades on XNAS, with a market cap of about $9.16B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.

Is IMVT good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IMVT for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.